reboxetine has been researched along with Anxiety Neuroses in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayres, R; Cowen, PJ; Favaron, E; Goodwin, GM; Harmer, CJ; Massey-Chase, R; O'Sullivan, U; Reinecke, A | 1 |
Cowen, PJ; Harmer, CJ; McCabe, C; Mishor, Z | 1 |
Cowen, PJ; Goodwin, GM; Harmer, CJ; Shelley, NC | 1 |
Leon, AC; Nelson, JC; Portera, L | 1 |
4 trial(s) available for reboxetine and Anxiety Neuroses
Article | Year |
---|---|
Effect of acute antidepressant administration on negative affective bias in depressed patients.
Topics: Adolescent; Adult; Affect; Antidepressive Agents; Anxiety Disorders; Depression; Depressive Disorder; Emotions; Facial Expression; Female; Humans; Male; Memory; Middle Aged; Morpholines; Personality; Personality Inventory; Reboxetine; Recognition, Psychology; Visual Perception | 2009 |
Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.
Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Anxiety Disorders; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Morpholines; Nerve Net; Reboxetine; Reward; Selective Serotonin Reuptake Inhibitors; Young Adult | 2010 |
Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Anger; Anxiety Disorders; Citalopram; Cognition; Depressive Disorder; Double-Blind Method; Facial Expression; Fear; Female; Hostility; Humans; Male; Memory; Morpholines; Placebos; Reboxetine; Recognition, Psychology; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Social Perception; Surveys and Questionnaires; Visual Perception | 2004 |
Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety Disorders; Depression; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Libido; Male; Morpholines; Norepinephrine; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Wake Disorders; Treatment Outcome | 2005 |